Breast Cancer
News
FDA Approves Test for HER2 Gene in Breast Cancer Tissue
News
FDA Approves Test for HER2 Gene in Breast Cancer Tissue
News
Protein Expression Marker May Predict Response to Anthracyclines
Major Finding: Overexpression of TOP2A protein in breast cancer was found to be predictive of response to anthracyclines, independent of HER2 gene...
News
Protein Expression Marker May Predict Response to Anthracyclines
Major Finding: Overexpression of TOP2A protein in breast cancer was found to be predictive of response to anthracyclines, independent of HER2 gene...
News
Screen Breast Cancer Patients for Depression
Major Finding: Women whose depression scores improved during a 1-year treatment trial for metastatic breast cancer lived a median 53.6 months...
News
Carboplatin Adds No Benefit to Standard Therapy for Basal-Like Breast Cancer
Major Finding: The pCR rate in basal-like breast cancer was 35% for standard chemotherapy with epirubicin, cyclophosphamide, and docetaxel, and 30...
News
Study: Flaxseed Bars Not Effective in Reducing Hot Flashes
Major Finding: Mean hot flash scores decreased by 4.9 units (about 33%) in the flaxseed arm, and by 3.5 (about 29%) in the placebo arm (P = .29)....
News
Bevacizumab Shows Promise for High-Risk Ovarian Cancer
Major Finding: Relative to chemotherapy alone, chemotherapy plus bevacizumab was associated with a nonsignificant 15% reduction in the risk of...
News
Exemestane Prevents 65% of Invasive Breast Cancers in Postmenopausal Women
Major Finding: The annual incidence of invasive breast cancer was 0.19% with exemestane vs. 0.55% with placebo (hazard ratio 0.35, P = .002).Data...
News
Exemestane Prevents Breast Cancers in Postmenopausal Women
Major Finding: The annual incidence of invasive breast cancer was 0.19% with exemestane vs. 0.55% with placebo (hazard ratio 0.35, P = .002).Data...